Try our Advanced Search for more refined results
October 01, 2010
TEVA NEUROSCIENCE, INC. et al v. WATSON PHARMA, INC. et al
Case Number:
2:10-cv-05078
Court:
Nature of Suit:
Judge:
Firms
- Buchanan Ingersoll
- Connell Foley
- Duane Morris
- Latham & Watkins
- Lite DePalma
- Mandelbaum Barrett
- Patunas Law
- Perkins Coie
- Rivkin Radler
- Saiber LLC
- Troutman Pepper
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 16, 2013
Teva Wins Ban On Mylan Parkinson's Generic
A New Jersey federal judge on Friday barred Mylan Inc. from manufacturing, importing or selling its own version of Teva Pharmaceutical Industries Ltd.'s brand-name treatment for Parkinson's disease, Azilect, for more than three years, after the generic-drug maker stipulated its proposed generic infringed a Teva patent.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login